Alphatec Holdings, Inc. (NASDAQ: ATEC) is a Healthcare company (Medical - Devices) with a market capitalization of $1.1B. The Maz Rating grades it against the other companies in its sector.
Alphatec Holdings, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $6.94, Alphatec Holdings, Inc. trades at 1.3x sales and 51.1x book value, with an EV/EBITDA of 49.2. Over the last twelve months it generated about $843M of revenue and a net loss of $87M. It runs a gross margin of 66.7%, an operating margin of -3.1% and a net margin of -10.3%. It shows return on equity of -547.2%, return on invested capital of -4.1% and a free cash flow yield of 0.5%. On the balance sheet: a debt-to-equity ratio of 27.88 and a current ratio of 2.36. Over the past 52 weeks the share price ranged from $6.71 to $23.29, with a beta of 0.78.
Alphatec Holdings, Inc. does not currently pay a dividend.
21 Wall Street analyst ratings cover the stock: 17 Buy, 3 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.